ORZEYFUL

This brand name is authorized in United States.

Active ingredients

The drug ORZEYFUL contains one active pharmaceutical ingredient (API):

`1`	Oveporexton UNII `59MF6P2ATF` - OVEPOREXTON
	The mechanism of action of oveporexton in the treatment of narcolepsy type 1 (NT1) is through agonism of the orexin receptor 2 (OX2R). NT1 is associated with the loss of orexin neuropeptide signaling.
	Read more about Oveporexton

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ORZEYFUL Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	64764-205, 64764-210, 64764-220

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.